7Baggers
 Casi Pharmaceuticals Q3 revenue drops 60%, net loss widens  MarketScreener Fri, 14 Nov 2025 21:19:20 GMT
 CASI Pharmaceuticals Appeals Nasdaq Delisting Determination  TipRanks Mon, 10 Nov 2025 22:28:23 GMT
 CASI Pharmaceuticals Advances CID-103 in Promising ITP Study  TipRanks Mon, 27 Oct 2025 07:00:00 GMT
 casi pharmaceuticals, inc. (casi) stock price, news, quote and history  Yahoo! Finance UK Wed, 22 Oct 2025 20:19:23 GMT
 published on: 2025-10-21 17:12:14  newser.com Tue, 21 Oct 2025 22:12:14 GMT
 how casi pharmaceuticals inc. stock reacts to bond yields - earnings beat & detailed earnings play alerts  Trung tâm Dự báo KTTV quốc gia Sat, 18 Oct 2025 06:49:27 GMT
 msn money  MSN Wed, 15 Oct 2025 07:30:43 GMT

CASI Pharmaceuticals, Inc
(NASDAQ:CASI) 

CASI stock logo

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. The company offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell t...

Founded: 1991
Full Time Employees: 125
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends